Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery
NCT02550145
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hypoglycemia
Interventions
DRUG:
Exendin (9-39)
OTHER:
Placebo
Sponsor
Tracey McLaughlin